Rapid and Substantial Gains in Implant Use, Share of Method Mix, and Contribution to mCPR Gains, Married Women, All Countries With PMA2020 Family Planning Briefs Posted Online in January and February 2018
Column 1 | Column 2 | Column 3 | Column 4 | Column 5 | Column 6 | Column 7 | Column 8 |
---|---|---|---|---|---|---|---|
Country and Data Source | mCPR (%) | Implant CPR (%) | Implant Share of Method Mix (%) | Injectable CPR (%) | Injectable Share of Method Mix (%) | mCPR Annual Gain, 2016 to 2017 (pp) | Implant CPR Annual Gain, 2016 to 2017 (pp) |
DRC/K PMA R6 2017 | 26.7 | 10.1 | 37.9 | 5.2a | 19.5a | 3.3 | 3.4 |
DRC/K PMA R5 2016 | 23.4 | 6.7 | 28.6 | 3.1a | 13.3a | ||
Ghana PMA R6 2017 | 27.4 | 8.4 | 30.7 | 7.8 | 28.5 | 1.6 | 2.5 |
Ghana PMA R5 2016 | 25.8 | 5.9 | 23.0 | 8.4 | 32.6 | ||
Niger PMA R2 2017 | 18.1 | 3.1 | 17.1 | 7.3 | 40.3a | 3.7 | 1.4 |
Niger PMA R1 2016 | 14.4 | 1.7 | 11.9 | 5.0 | 34.9 |
Abbreviations: CPR, contraceptive prevalence rate; DMPA, depot medroxyprogesterone acetate; DRC/K, Democratic Republic of the Congo/Kinshasa only; mCPR, modern contraceptive prevalence rate; PMA, Performance Monitoring and Accountability 2020; pp, percentage point; R, round.
↵a Sum of the intramuscular DMPA injectable and the subcutaneous injectable Sayana Press.